CNFN | Cornifelin | Predicted intracellular proteins
| | | | | Group enriched |
SPINK5 | Serine peptidase inhibitor, Kazal type 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RPTN | Repetin | Predicted intracellular proteins
| | | | | Group enriched |
PI3 | Peptidase inhibitor 3, skin-derived | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LYPD3 | LY6/PLAUR domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CLDN17 | Claudin 17 | Predicted membrane proteins
| | | | | Group enriched |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
TRIM29 | Tripartite motif containing 29 | Predicted intracellular proteins
| | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
S100A8 | S100 calcium binding protein A8 | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
S100A7 | S100 calcium binding protein A7 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
ALOX12B | Arachidonate 12-lipoxygenase, 12R type | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Group enriched |
S100A7A | S100 calcium binding protein A7A | Predicted intracellular proteins
| | | | | Tissue enriched |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SP140 | SP140 nuclear body protein | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |